Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study - 24/06/21
, John W Glasser, PhD eSummary |
Background |
A rubella vaccine was licensed in China in 1993 and added to the Expanded Programme on Immunization in 2008, but a national cross-sectional serological survey during 2014 indicates that many adolescents remain susceptible. Maternal infections during the first trimester often cause miscarriages, stillbirths, and, among livebirths, congenital rubella syndrome. We aimed to evaluate possible supplemental immunisation activities (SIAs) to accelerate elimination of rubella and congenital rubella syndrome.
Methods |
We analysed residual samples from the national serological survey done in 2014, data from monthly rubella surveillance reports from 2005 and 2016, and additional publications through a systematic review. Using an age-structured population model with provincial strata, we calculated the reproduction numbers and evaluated the gradient of the metapopulation effective reproduction number with respect to potential supplemental immunisation rates. We corroborated these analytical results and estimated times-to-elimination by simulating SIAs among adolescents (ages 10–19 years) and young adults (ages 20–29 years) using a model with regional strata. We estimated the incidence of rubella and burden of congenital rubella syndrome by simulating transmission in a relatively small population lacking only spatial structure.
Findings |
By 2014, childhood immunisation had reduced rubella’s reproduction number from 7·6 to 1·2 and SIAs among adolescents were the optimal elimination strategy. We found that less than 10% of rubella infections were reported; that although some women with symptomatic first-trimester infections might have elected to terminate their pregnancies, 700 children could have been born with congenital rubella syndrome during 2014; and that timely SIAs would avert outbreaks that, as susceptible adolescents reached reproductive age, could greatly increase the burden of this syndrome.
Interpretation |
Our findings suggest that SIAs among adolescents would most effectively reduce congenital rubella syndrome as well as eliminate rubella, owing both to fewer infections in the immunised population and absence of infections that those immunised would otherwise have caused. Metapopulation models with realistic mixing are uniquely capable of assessing such indirect effects.
Funding |
WHO and National Science Foundation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 21 - N° 7
P. 1004-1013 - juillet 2021 Retour au numéro
Article précédent
- BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial
- Sarah Prentice, Beatrice Nassanga, Emily L Webb, Florence Akello, Fred Kiwudhu, Hellen Akurut, Alison M Elliott, Rob J W Arts, Mihai G Netea, Hazel M Dockrell, Stephen Cose, The Delayed BCG Study Team, Sarah Prentice, Beatrice Nassanga, Hellen Akurut, Florence Akello, Fred Kiwudhu, Stephen Cose, Hazel Dockrell, Emily Webb, Alison Elliott, Irene Nabaweesi, Christopher Zziwa, Milly Namutebi, Benigna Namarra, Florence Akello, Esther Nakazibwe, Susan Amongi, Grace Kamukama, Susan Iwala, Caroline Ninsiima, Josephine Tumusiime, Fred Kiwanuka, Saadn Nsubuga, Justin Akello, Sebastian Owilla, Jonathan Levin, Stephen Nash, Prossy Kabuubi Nakawungu, Elson Abayo, Grace Nabakooza, Zephyrian Kaushaaga, Miriam Akello
- Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis
- Sorawat Sangkaew, Damien Ming, Adhiratha Boonyasiri, Kate Honeyford, Siripen Kalayanarooj, Sophie Yacoub, Ilaria Dorigatti, Alison Holmes
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?